Am J Transl Res:过敏性鼻炎中细胞自噬调节上皮屏障功能

2020-08-08 AlexYang MedSci原创

过敏性鼻炎(AR)中总是出现上皮障碍缺损,从而利于过敏原的浸润。最近,有研究人员调查了AR中细胞自噬在上皮障碍缺损中的作用以及相关的信号途径。

过敏性鼻炎(AR)中总是出现上皮障碍缺损,从而利于过敏原的浸润。最近,有研究人员调查了AR中细胞自噬在上皮障碍缺损中的作用以及相关的信号途径。

研究人员使用尘螨过敏原(Derp1)处理人鼻上皮细胞系。通过GFP-LC3腺病毒转染和自噬相关蛋白的测量来评估自噬情况,并测量紧密连接蛋白的表达、经上皮的电阻和荧光素异硫氰酸酯-葡聚糖(FD4)的渗透性来评估上皮屏障功能。另外,研究人员还使用miR-125b抑制剂、miR-125b类似物、靶向FoxP3的shRNA、表达FoxP3的pcDNA3.1和4型C-X-C基序趋化因子受体(CXCR4)抑制剂调查miR-125b、FoxP3和CXCR4在上皮细胞自噬和上皮屏障功能中的功能。研究人员将大鼠鼻粘膜暴露于过敏原来产生AR模型。研究发现,Derp 1暴露能够增强细胞自噬和损伤上皮细胞的上皮屏障。

尘螨过敏原促进鼻上皮细胞自噬和损伤上皮屏障的功能

miR-125b表达的上调能够通过抑制Foxp3增强细胞自噬和损伤上皮屏障。Derp 1还能通过增加CXCR4的表达和激活CXCR4增加miR-125b的表达,进一步下调FoxP3表达并导致细胞自噬增加和损伤上皮屏障。体内分析确定了CXCR4/miR-125b/FoxP3在AR上皮屏障损伤中的功能。

过敏原通过调控CXCR4/miR-125b/FoxP3影响细胞自噬和上皮屏障

最后,研究人员指出,CXCR4/miR-125b/FoxP3可能参与了AR的致病过程,主要是通过调控上皮细胞的自噬和上皮屏障的功能。

原始出处:

Jing Zheng, Min Zeng, Jia-Bin Nian et al. The CXCR4/miR-125b/FoxP3 axis regulates the function of the epithelial barrier via autophagy in allergic rhinitis. Am J Transl Res. 2020

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2022471, encodeId=3c3d20224e101, content=<a href='/topic/show?id=5b4d4e717dd' target=_blank style='color:#2F92EE;'>#屏障功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47717, encryptionId=5b4d4e717dd, topicName=屏障功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Fri Nov 13 14:00:15 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067512, encodeId=d543206e51201, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed Sep 23 07:00:15 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685815, encodeId=eaa91685815a9, content=<a href='/topic/show?id=4d542001925' target=_blank style='color:#2F92EE;'>#上皮屏障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20019, encryptionId=4d542001925, topicName=上皮屏障)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=252e28283320, createdName=ms6829001416292975, createdTime=Sat Jun 05 19:00:15 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657352, encodeId=7cac165e35262, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Fri Oct 23 05:00:15 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891909, encodeId=085d891909e8, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25915252522, createdName=147e4799m34暂无昵称, createdTime=Tue Oct 13 23:50:59 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047288, encodeId=e2ab204e28892, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Jan 02 22:00:15 CST 2021, time=2021-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299349, encodeId=a3c9129934921, content=<a href='/topic/show?id=1dd5e8010f5' target=_blank style='color:#2F92EE;'>#细胞自噬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78010, encryptionId=1dd5e8010f5, topicName=细胞自噬)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Mon Aug 10 06:00:15 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807034, encodeId=acf880e034c1, content=棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200730/d09d5c70e4e74843b58d9c0914703eb3/3cc8e9c746234f5e9b4b5bf420083caf.jpg, createdBy=dbdb5403691, createdName=忘忧草crush, createdTime=Sun Aug 09 01:00:28 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806989, encodeId=df29806989ba, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cc55399353, createdName=ms8000000888122098, createdTime=Sat Aug 08 19:49:33 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806943, encodeId=2f598069439d, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpfibzxGQzmZc2lK2M6rl2N86FnEia9Kt17bpXex3WWxYsCoPtHmIdUyv1Q9RvfiaicnPuNmAy5dbAOw/132, createdBy=f0265286154, createdName=杰1430, createdTime=Sat Aug 08 16:25:08 CST 2020, time=2020-08-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2022471, encodeId=3c3d20224e101, content=<a href='/topic/show?id=5b4d4e717dd' target=_blank style='color:#2F92EE;'>#屏障功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47717, encryptionId=5b4d4e717dd, topicName=屏障功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Fri Nov 13 14:00:15 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067512, encodeId=d543206e51201, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed Sep 23 07:00:15 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685815, encodeId=eaa91685815a9, content=<a href='/topic/show?id=4d542001925' target=_blank style='color:#2F92EE;'>#上皮屏障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20019, encryptionId=4d542001925, topicName=上皮屏障)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=252e28283320, createdName=ms6829001416292975, createdTime=Sat Jun 05 19:00:15 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657352, encodeId=7cac165e35262, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Fri Oct 23 05:00:15 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891909, encodeId=085d891909e8, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25915252522, createdName=147e4799m34暂无昵称, createdTime=Tue Oct 13 23:50:59 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047288, encodeId=e2ab204e28892, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Jan 02 22:00:15 CST 2021, time=2021-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299349, encodeId=a3c9129934921, content=<a href='/topic/show?id=1dd5e8010f5' target=_blank style='color:#2F92EE;'>#细胞自噬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78010, encryptionId=1dd5e8010f5, topicName=细胞自噬)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Mon Aug 10 06:00:15 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807034, encodeId=acf880e034c1, content=棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200730/d09d5c70e4e74843b58d9c0914703eb3/3cc8e9c746234f5e9b4b5bf420083caf.jpg, createdBy=dbdb5403691, createdName=忘忧草crush, createdTime=Sun Aug 09 01:00:28 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806989, encodeId=df29806989ba, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cc55399353, createdName=ms8000000888122098, createdTime=Sat Aug 08 19:49:33 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806943, encodeId=2f598069439d, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpfibzxGQzmZc2lK2M6rl2N86FnEia9Kt17bpXex3WWxYsCoPtHmIdUyv1Q9RvfiaicnPuNmAy5dbAOw/132, createdBy=f0265286154, createdName=杰1430, createdTime=Sat Aug 08 16:25:08 CST 2020, time=2020-08-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2022471, encodeId=3c3d20224e101, content=<a href='/topic/show?id=5b4d4e717dd' target=_blank style='color:#2F92EE;'>#屏障功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47717, encryptionId=5b4d4e717dd, topicName=屏障功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Fri Nov 13 14:00:15 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067512, encodeId=d543206e51201, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed Sep 23 07:00:15 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685815, encodeId=eaa91685815a9, content=<a href='/topic/show?id=4d542001925' target=_blank style='color:#2F92EE;'>#上皮屏障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20019, encryptionId=4d542001925, topicName=上皮屏障)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=252e28283320, createdName=ms6829001416292975, createdTime=Sat Jun 05 19:00:15 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657352, encodeId=7cac165e35262, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Fri Oct 23 05:00:15 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891909, encodeId=085d891909e8, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25915252522, createdName=147e4799m34暂无昵称, createdTime=Tue Oct 13 23:50:59 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047288, encodeId=e2ab204e28892, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Jan 02 22:00:15 CST 2021, time=2021-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299349, encodeId=a3c9129934921, content=<a href='/topic/show?id=1dd5e8010f5' target=_blank style='color:#2F92EE;'>#细胞自噬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78010, encryptionId=1dd5e8010f5, topicName=细胞自噬)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Mon Aug 10 06:00:15 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807034, encodeId=acf880e034c1, content=棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200730/d09d5c70e4e74843b58d9c0914703eb3/3cc8e9c746234f5e9b4b5bf420083caf.jpg, createdBy=dbdb5403691, createdName=忘忧草crush, createdTime=Sun Aug 09 01:00:28 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806989, encodeId=df29806989ba, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cc55399353, createdName=ms8000000888122098, createdTime=Sat Aug 08 19:49:33 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806943, encodeId=2f598069439d, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpfibzxGQzmZc2lK2M6rl2N86FnEia9Kt17bpXex3WWxYsCoPtHmIdUyv1Q9RvfiaicnPuNmAy5dbAOw/132, createdBy=f0265286154, createdName=杰1430, createdTime=Sat Aug 08 16:25:08 CST 2020, time=2020-08-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2022471, encodeId=3c3d20224e101, content=<a href='/topic/show?id=5b4d4e717dd' target=_blank style='color:#2F92EE;'>#屏障功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47717, encryptionId=5b4d4e717dd, topicName=屏障功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Fri Nov 13 14:00:15 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067512, encodeId=d543206e51201, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed Sep 23 07:00:15 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685815, encodeId=eaa91685815a9, content=<a href='/topic/show?id=4d542001925' target=_blank style='color:#2F92EE;'>#上皮屏障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20019, encryptionId=4d542001925, topicName=上皮屏障)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=252e28283320, createdName=ms6829001416292975, createdTime=Sat Jun 05 19:00:15 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657352, encodeId=7cac165e35262, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Fri Oct 23 05:00:15 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891909, encodeId=085d891909e8, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25915252522, createdName=147e4799m34暂无昵称, createdTime=Tue Oct 13 23:50:59 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047288, encodeId=e2ab204e28892, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Jan 02 22:00:15 CST 2021, time=2021-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299349, encodeId=a3c9129934921, content=<a href='/topic/show?id=1dd5e8010f5' target=_blank style='color:#2F92EE;'>#细胞自噬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78010, encryptionId=1dd5e8010f5, topicName=细胞自噬)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Mon Aug 10 06:00:15 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807034, encodeId=acf880e034c1, content=棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200730/d09d5c70e4e74843b58d9c0914703eb3/3cc8e9c746234f5e9b4b5bf420083caf.jpg, createdBy=dbdb5403691, createdName=忘忧草crush, createdTime=Sun Aug 09 01:00:28 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806989, encodeId=df29806989ba, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cc55399353, createdName=ms8000000888122098, createdTime=Sat Aug 08 19:49:33 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806943, encodeId=2f598069439d, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpfibzxGQzmZc2lK2M6rl2N86FnEia9Kt17bpXex3WWxYsCoPtHmIdUyv1Q9RvfiaicnPuNmAy5dbAOw/132, createdBy=f0265286154, createdName=杰1430, createdTime=Sat Aug 08 16:25:08 CST 2020, time=2020-08-08, status=1, ipAttribution=)]
    2020-10-23 bsmagic9140
  5. [GetPortalCommentsPageByObjectIdResponse(id=2022471, encodeId=3c3d20224e101, content=<a href='/topic/show?id=5b4d4e717dd' target=_blank style='color:#2F92EE;'>#屏障功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47717, encryptionId=5b4d4e717dd, topicName=屏障功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Fri Nov 13 14:00:15 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067512, encodeId=d543206e51201, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed Sep 23 07:00:15 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685815, encodeId=eaa91685815a9, content=<a href='/topic/show?id=4d542001925' target=_blank style='color:#2F92EE;'>#上皮屏障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20019, encryptionId=4d542001925, topicName=上皮屏障)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=252e28283320, createdName=ms6829001416292975, createdTime=Sat Jun 05 19:00:15 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657352, encodeId=7cac165e35262, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Fri Oct 23 05:00:15 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891909, encodeId=085d891909e8, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25915252522, createdName=147e4799m34暂无昵称, createdTime=Tue Oct 13 23:50:59 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047288, encodeId=e2ab204e28892, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Jan 02 22:00:15 CST 2021, time=2021-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299349, encodeId=a3c9129934921, content=<a href='/topic/show?id=1dd5e8010f5' target=_blank style='color:#2F92EE;'>#细胞自噬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78010, encryptionId=1dd5e8010f5, topicName=细胞自噬)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Mon Aug 10 06:00:15 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807034, encodeId=acf880e034c1, content=棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200730/d09d5c70e4e74843b58d9c0914703eb3/3cc8e9c746234f5e9b4b5bf420083caf.jpg, createdBy=dbdb5403691, createdName=忘忧草crush, createdTime=Sun Aug 09 01:00:28 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806989, encodeId=df29806989ba, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cc55399353, createdName=ms8000000888122098, createdTime=Sat Aug 08 19:49:33 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806943, encodeId=2f598069439d, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpfibzxGQzmZc2lK2M6rl2N86FnEia9Kt17bpXex3WWxYsCoPtHmIdUyv1Q9RvfiaicnPuNmAy5dbAOw/132, createdBy=f0265286154, createdName=杰1430, createdTime=Sat Aug 08 16:25:08 CST 2020, time=2020-08-08, status=1, ipAttribution=)]
    2020-10-13 147e4799m34暂无昵称

    很有用

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2022471, encodeId=3c3d20224e101, content=<a href='/topic/show?id=5b4d4e717dd' target=_blank style='color:#2F92EE;'>#屏障功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47717, encryptionId=5b4d4e717dd, topicName=屏障功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Fri Nov 13 14:00:15 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067512, encodeId=d543206e51201, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed Sep 23 07:00:15 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685815, encodeId=eaa91685815a9, content=<a href='/topic/show?id=4d542001925' target=_blank style='color:#2F92EE;'>#上皮屏障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20019, encryptionId=4d542001925, topicName=上皮屏障)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=252e28283320, createdName=ms6829001416292975, createdTime=Sat Jun 05 19:00:15 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657352, encodeId=7cac165e35262, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Fri Oct 23 05:00:15 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891909, encodeId=085d891909e8, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25915252522, createdName=147e4799m34暂无昵称, createdTime=Tue Oct 13 23:50:59 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047288, encodeId=e2ab204e28892, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Jan 02 22:00:15 CST 2021, time=2021-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299349, encodeId=a3c9129934921, content=<a href='/topic/show?id=1dd5e8010f5' target=_blank style='color:#2F92EE;'>#细胞自噬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78010, encryptionId=1dd5e8010f5, topicName=细胞自噬)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Mon Aug 10 06:00:15 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807034, encodeId=acf880e034c1, content=棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200730/d09d5c70e4e74843b58d9c0914703eb3/3cc8e9c746234f5e9b4b5bf420083caf.jpg, createdBy=dbdb5403691, createdName=忘忧草crush, createdTime=Sun Aug 09 01:00:28 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806989, encodeId=df29806989ba, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cc55399353, createdName=ms8000000888122098, createdTime=Sat Aug 08 19:49:33 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806943, encodeId=2f598069439d, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpfibzxGQzmZc2lK2M6rl2N86FnEia9Kt17bpXex3WWxYsCoPtHmIdUyv1Q9RvfiaicnPuNmAy5dbAOw/132, createdBy=f0265286154, createdName=杰1430, createdTime=Sat Aug 08 16:25:08 CST 2020, time=2020-08-08, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=2022471, encodeId=3c3d20224e101, content=<a href='/topic/show?id=5b4d4e717dd' target=_blank style='color:#2F92EE;'>#屏障功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47717, encryptionId=5b4d4e717dd, topicName=屏障功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Fri Nov 13 14:00:15 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067512, encodeId=d543206e51201, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed Sep 23 07:00:15 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685815, encodeId=eaa91685815a9, content=<a href='/topic/show?id=4d542001925' target=_blank style='color:#2F92EE;'>#上皮屏障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20019, encryptionId=4d542001925, topicName=上皮屏障)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=252e28283320, createdName=ms6829001416292975, createdTime=Sat Jun 05 19:00:15 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657352, encodeId=7cac165e35262, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Fri Oct 23 05:00:15 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891909, encodeId=085d891909e8, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25915252522, createdName=147e4799m34暂无昵称, createdTime=Tue Oct 13 23:50:59 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047288, encodeId=e2ab204e28892, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Jan 02 22:00:15 CST 2021, time=2021-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299349, encodeId=a3c9129934921, content=<a href='/topic/show?id=1dd5e8010f5' target=_blank style='color:#2F92EE;'>#细胞自噬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78010, encryptionId=1dd5e8010f5, topicName=细胞自噬)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Mon Aug 10 06:00:15 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807034, encodeId=acf880e034c1, content=棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200730/d09d5c70e4e74843b58d9c0914703eb3/3cc8e9c746234f5e9b4b5bf420083caf.jpg, createdBy=dbdb5403691, createdName=忘忧草crush, createdTime=Sun Aug 09 01:00:28 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806989, encodeId=df29806989ba, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cc55399353, createdName=ms8000000888122098, createdTime=Sat Aug 08 19:49:33 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806943, encodeId=2f598069439d, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpfibzxGQzmZc2lK2M6rl2N86FnEia9Kt17bpXex3WWxYsCoPtHmIdUyv1Q9RvfiaicnPuNmAy5dbAOw/132, createdBy=f0265286154, createdName=杰1430, createdTime=Sat Aug 08 16:25:08 CST 2020, time=2020-08-08, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=2022471, encodeId=3c3d20224e101, content=<a href='/topic/show?id=5b4d4e717dd' target=_blank style='color:#2F92EE;'>#屏障功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47717, encryptionId=5b4d4e717dd, topicName=屏障功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Fri Nov 13 14:00:15 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067512, encodeId=d543206e51201, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed Sep 23 07:00:15 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685815, encodeId=eaa91685815a9, content=<a href='/topic/show?id=4d542001925' target=_blank style='color:#2F92EE;'>#上皮屏障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20019, encryptionId=4d542001925, topicName=上皮屏障)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=252e28283320, createdName=ms6829001416292975, createdTime=Sat Jun 05 19:00:15 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657352, encodeId=7cac165e35262, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Fri Oct 23 05:00:15 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891909, encodeId=085d891909e8, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25915252522, createdName=147e4799m34暂无昵称, createdTime=Tue Oct 13 23:50:59 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047288, encodeId=e2ab204e28892, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Jan 02 22:00:15 CST 2021, time=2021-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299349, encodeId=a3c9129934921, content=<a href='/topic/show?id=1dd5e8010f5' target=_blank style='color:#2F92EE;'>#细胞自噬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78010, encryptionId=1dd5e8010f5, topicName=细胞自噬)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Mon Aug 10 06:00:15 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807034, encodeId=acf880e034c1, content=棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200730/d09d5c70e4e74843b58d9c0914703eb3/3cc8e9c746234f5e9b4b5bf420083caf.jpg, createdBy=dbdb5403691, createdName=忘忧草crush, createdTime=Sun Aug 09 01:00:28 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806989, encodeId=df29806989ba, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cc55399353, createdName=ms8000000888122098, createdTime=Sat Aug 08 19:49:33 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806943, encodeId=2f598069439d, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpfibzxGQzmZc2lK2M6rl2N86FnEia9Kt17bpXex3WWxYsCoPtHmIdUyv1Q9RvfiaicnPuNmAy5dbAOw/132, createdBy=f0265286154, createdName=杰1430, createdTime=Sat Aug 08 16:25:08 CST 2020, time=2020-08-08, status=1, ipAttribution=)]
    2020-08-09 忘忧草crush

    棒!

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2022471, encodeId=3c3d20224e101, content=<a href='/topic/show?id=5b4d4e717dd' target=_blank style='color:#2F92EE;'>#屏障功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47717, encryptionId=5b4d4e717dd, topicName=屏障功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Fri Nov 13 14:00:15 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067512, encodeId=d543206e51201, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed Sep 23 07:00:15 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685815, encodeId=eaa91685815a9, content=<a href='/topic/show?id=4d542001925' target=_blank style='color:#2F92EE;'>#上皮屏障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20019, encryptionId=4d542001925, topicName=上皮屏障)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=252e28283320, createdName=ms6829001416292975, createdTime=Sat Jun 05 19:00:15 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657352, encodeId=7cac165e35262, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Fri Oct 23 05:00:15 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891909, encodeId=085d891909e8, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25915252522, createdName=147e4799m34暂无昵称, createdTime=Tue Oct 13 23:50:59 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047288, encodeId=e2ab204e28892, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Jan 02 22:00:15 CST 2021, time=2021-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299349, encodeId=a3c9129934921, content=<a href='/topic/show?id=1dd5e8010f5' target=_blank style='color:#2F92EE;'>#细胞自噬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78010, encryptionId=1dd5e8010f5, topicName=细胞自噬)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Mon Aug 10 06:00:15 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807034, encodeId=acf880e034c1, content=棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200730/d09d5c70e4e74843b58d9c0914703eb3/3cc8e9c746234f5e9b4b5bf420083caf.jpg, createdBy=dbdb5403691, createdName=忘忧草crush, createdTime=Sun Aug 09 01:00:28 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806989, encodeId=df29806989ba, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cc55399353, createdName=ms8000000888122098, createdTime=Sat Aug 08 19:49:33 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806943, encodeId=2f598069439d, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpfibzxGQzmZc2lK2M6rl2N86FnEia9Kt17bpXex3WWxYsCoPtHmIdUyv1Q9RvfiaicnPuNmAy5dbAOw/132, createdBy=f0265286154, createdName=杰1430, createdTime=Sat Aug 08 16:25:08 CST 2020, time=2020-08-08, status=1, ipAttribution=)]
    2020-08-08 ms8000000888122098

    受教了

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2022471, encodeId=3c3d20224e101, content=<a href='/topic/show?id=5b4d4e717dd' target=_blank style='color:#2F92EE;'>#屏障功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47717, encryptionId=5b4d4e717dd, topicName=屏障功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Fri Nov 13 14:00:15 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067512, encodeId=d543206e51201, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Wed Sep 23 07:00:15 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685815, encodeId=eaa91685815a9, content=<a href='/topic/show?id=4d542001925' target=_blank style='color:#2F92EE;'>#上皮屏障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20019, encryptionId=4d542001925, topicName=上皮屏障)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=252e28283320, createdName=ms6829001416292975, createdTime=Sat Jun 05 19:00:15 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657352, encodeId=7cac165e35262, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Fri Oct 23 05:00:15 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891909, encodeId=085d891909e8, content=很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25915252522, createdName=147e4799m34暂无昵称, createdTime=Tue Oct 13 23:50:59 CST 2020, time=2020-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047288, encodeId=e2ab204e28892, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Sat Jan 02 22:00:15 CST 2021, time=2021-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299349, encodeId=a3c9129934921, content=<a href='/topic/show?id=1dd5e8010f5' target=_blank style='color:#2F92EE;'>#细胞自噬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78010, encryptionId=1dd5e8010f5, topicName=细胞自噬)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Mon Aug 10 06:00:15 CST 2020, time=2020-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807034, encodeId=acf880e034c1, content=棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200730/d09d5c70e4e74843b58d9c0914703eb3/3cc8e9c746234f5e9b4b5bf420083caf.jpg, createdBy=dbdb5403691, createdName=忘忧草crush, createdTime=Sun Aug 09 01:00:28 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806989, encodeId=df29806989ba, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cc55399353, createdName=ms8000000888122098, createdTime=Sat Aug 08 19:49:33 CST 2020, time=2020-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806943, encodeId=2f598069439d, content=好东西, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpfibzxGQzmZc2lK2M6rl2N86FnEia9Kt17bpXex3WWxYsCoPtHmIdUyv1Q9RvfiaicnPuNmAy5dbAOw/132, createdBy=f0265286154, createdName=杰1430, createdTime=Sat Aug 08 16:25:08 CST 2020, time=2020-08-08, status=1, ipAttribution=)]
    2020-08-08 杰1430

    好东西

    0

相关资讯

Cell Death Dis:西达本胺通过表观遗传修饰抑制细胞自噬发挥抗骨髓瘤活性

细胞自噬过程会导致异常的细胞质组分出现自噬小体依赖性的溶酶体降解反应,其涉及了一系列以如LC3B1-3在内的自噬相关(ATG)蛋白为核心组成的细胞膜动态重塑过程。

Toxicol Lett:下调GSK-3β来增强细胞自噬能够减轻铂诱导的耳毒性

之前的研究报道了选择性GSK-3β抑制剂或者上调细胞自噬能够减轻铂诱导的耳毒性。其他研究表明了GSK-3β的活性与细胞自噬水平紧密相关。最近,有研究人员初步探索了体内和体外中细胞自噬在GSK-3β抑制剂减轻铂诱导的听力损失方面的影响。研究人员在铂诱导的耳毒性小鼠模型中观察到了由GSK-3β抑制剂诱导的外听毛细胞(OHCs)细胞自噬的变化。另外,研究人员利用细胞自噬抑制剂3-MA在体外试验中观察GS

Cell Death Dis:Dram1缺乏加速结核分枝杆菌感染的巨噬细胞焦亡

细胞自噬是一种细胞内降解机制,其作用是维持体内的稳态,并在体内稳态受到干扰时与细胞程序死亡相互启动行使作用。细胞自噬可以由多种应激源诱发,如营养缺乏、紫外线损伤以及感染。细胞自噬的防御机制为传染病的新

NATURE:胰腺癌是怎么逃过免疫监视的?

胰腺导管腺癌(PDAC)对包括ICB在内的大多数疗法具有耐药性。在PDAC中,导致MHC-I缺损的突变很少被发现,尽管MHC-I的表达被频繁下调。

Cell Death Dis:TNFAIP8调节细胞自噬、脂肪变性并促进肝癌细胞增殖

TNFAIP8(肿瘤坏死因子α诱导蛋白8)是TNFAIP8/TIPE蛋白家族的成员,该家族还包括TIPE1、TIPE2和TIPE3。TNFAIP8的表达与各种类型的肿瘤发生发展息息相关,其

Cell Death Dis:自噬抑制可增强紫杉醇类似物Alteronol的黑色素瘤细胞上皮-间质转化进程

黑色素瘤是由产生色素的黑色素细胞癌变引起的,是一种最具有侵略性的恶性皮肤癌,在所有与皮肤癌有关的死亡中占比高达80-85%,每年约有100,000死亡病例。